MarketCapTrends
RNAC
Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare

Cartesian Therapeutics Inc. Cash on Hand 2014–2025

Cartesian Therapeutics Inc. annual/quarterly cash on hand history from 2015 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Cartesian Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 125.1M, a 41.14% decrease year-over-year.
  • Cartesian Therapeutics Inc. cash on hand for 2025 were 125.1M, a 41.14% decrease from 2024.
  • Cartesian Therapeutics Inc. cash on hand for 2024 were 212.6M, a 176.44% increase from 2023.
  • Cartesian Therapeutics Inc. cash on hand for 2023 were 76.9M, a 27.74% decrease from 2022.
  • Cartesian Therapeutics Inc. cash on hand for 2022 were 106.4M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Cartesian Therapeutics Inc. Annual Cash on Hand (Millions of US $)
2025$125
2024$213
2023$77
2022$106
2021$114
2020$139
2019$90
2018$37
2017$71
2016$59
2015$32
Cartesian Therapeutics Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$125
2024-12-31$213
2023-12-31$77
2022-12-31$106
2021-12-31$114
2020-12-31$139
2019-12-31$90
2018-12-31$37
2017-12-31$71
2016-12-31$59
2015-12-31$32

Cartesian Therapeutics Inc. Cash on Hand — FAQ

Cartesian Therapeutics Inc. (RNAC) cash on hand over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RNAC's cash on hand history?

The chart and table above show Cartesian Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.